ABSTRACT
Hormone therapy (HT) is important and frequently used both regarding replacement therapy (HRT) and gender affirming therapy (GAHT). While HRT has been effective in addressing symptoms related to hormone shortage, several side effects have been described. In this context, there are some studies that show increased cardiovascular risk. However, there are also studies reporting protective aspects of HT. Nevertheless, the exact impact of HT on cardiovascular risk and the underlying mechanisms remain poorly understood. This article explores the relationship between diverse types of HT and cardiovascular risk, focusing on mechanistic insights of the underlying hormones on platelet and leukocyte function as well as on effects on endothelial and adipose tissue cells.
Subject(s)
Cardiovascular Diseases , Humans , Cardiovascular Diseases/prevention & control , Risk Factors , Hormone Replacement Therapy/adverse effects , Heart Disease Risk Factors , HormonesABSTRACT
In the recently published review titled "Update on Management of Cardiovascular Diseases in Women", Lucà et al. [...].
